Re‐treatment for immune globulin‐resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy
Top Cited Papers
- 28 June 2001
- journal article
- clinical trial
- Published by Wiley in Pediatrics International
- Vol. 43 (3) , 211-217
- https://doi.org/10.1046/j.1442-200x.2001.01373.x
Abstract
Background : We compared the efficacy and safety of additional intravenous immune globulin (IVIG) therapy with steroid pulse therapy in patients with IVIG‐resistant Kawasaki disease. Methods: Two‐hundred and sixty‐two consecutive patients had been treated with a single dose of IVIG (2 g/kg) and aspirin (30 mg/kg per day). Thirty‐five patients (13.4%) were not clinical responders to the initial IVIG treatment. They received an additional IVIG treatment (1 g/kg) within 48 h after the initial treatment. Seventeen patients (6.5%) did not respond to the additional IVIG treatment. We randomly divided these patients into two groups: group 1 consisted of eight patients who were treated with a single additional dose of IVIG (1 g/kg), while group 2 consisted of nine patients who were treated with steroid pulse therapy. Results : The IVIG‐resistant patients had a high incidence of coronary artery lesions (CAL; 48.6%). Five patients (62.5%) in group 1 had CAL, including two patients who each had a giant aneurysm and three patients who each had a small aneurysm. Seven patients (77.8%) in group 2 had CAL, including two patients who each had a giant aneurysm, two patients who each had a small coronary aneurysm and three patients who each showed transient dilatation during steroid pulse therapy. There was no significant difference in the incidence of CAL between the two groups. The duration of high fever in group 2 (1.4±0.7 days) was significantly shorter than in group 1 (4.8±3.4 days; PPConclusions : Steroid pulse therapy may be useful in the treatment of patients with IVIG‐resistant Kawasaki disease who experience prolonged fever. However, transient dilatation of the coronary artery is observed during steroid pulse therapy, so careful echocardiographic examination should be performed for those patients receiving steroid pulse therapy for the sake of early detection of coronary artery abnormalities.Keywords
This publication has 26 references indexed in Scilit:
- Rupture of coronary aneurysm in Kawasaki diseasePediatrics International, 1999
- Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroidsThe Journal of Pediatrics, 1996
- Gamma globulin re-treatment in Kawasaki diseaseThe Journal of Pediatrics, 1993
- Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesionsClinical Immunology and Immunopathology, 1990
- Kawasaki disease: Clinical perspectiveThe Journal of Pediatrics, 1987
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Myocardial infarction in Kawasaki disease: Clinical analyses in 195 casesThe Journal of Pediatrics, 1986
- Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up studyThe American Journal of Cardiology, 1982
- A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease.Japanese Circulation Journal, 1982
- Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndromePublished by Elsevier ,1975